1.
J Am Acad Dermatol
; 91(3): e59-e60, 2024 Sep.
Article
in English
| MEDLINE
| ID: mdl-38740331
2.
J Am Acad Dermatol
; 89(2S): S36-S39, 2023 08.
Article
in English
| MEDLINE
| ID: mdl-37591565
ABSTRACT
Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians' fingertips.